Herbal remedies, including Chinese herbal medicines (CHM), are being increasingly used in Australia. This may be attributed to immigration, a growing disillusionment with conventional medicine and an increasing awareness of alternative therapies in the community. There is a perception amongst consumers that these remedies are "natural" and have no adverse effects. However, some herbs, in particular those derived from the Aconitum species (aconite), are known to be extremely potent, with a low therapeutic index. Aconite cardiotoxicity, for which the management has remained a challenge, is well described I. We present a case of severe aconite-induced cardiotoxicity successfully managed with cardiopulmonary bypass (CPB) followed by the use of a ventricular assist device (V AD).
CASE REPORT
A 32-year-old Aboriginal man weighing 110 kg, height 193 cm, with chronic bilateral knee and elbow arthralgia presented to a Chinese herbalist for treatment. His past medical history included two episodes of decompression illness six years previously while employed as a pearl diver, one of these requiring recompression therapy. He was otherwise in good health, with no history of heart disease and on no regular medications.
Following consultation through an interpreter, the herbalist administered subcutaneous injections of an unknown substance over the affected joints, and prescribed and supplied the patient with five doses of Chinese herbs. The following morning the patient prepared a decoction of the Chinese herbs which was boiled for five to ten minutes. Approximately 30 minutes following ingestion the patient began to feel unwell, with symptoms of flushing of the forearms, heaviness of the limbs, tingling of the oral cavity and progressive unsteadiness and nausea. Now unable to drive, he was taken to a pre-arranged dental appointment. Treatment involved minor restorative work, no local anaesthetic was used and he was pain-free during the procedure. On rising from the chair he complained of lightheadedness and blurred vision. He collapsed, developed diarrhoea and complained of chest tightness, shortness of breath and nausea. A general practitioner was called who noted bradycardia and hypotension. Ambulance transfer to the Accident and Emergency Centre of The Prince of Wales Hospital was arranged.
On admission he was noted to be diaphoretic and peripherally shut down. Blood pressure was 95/50 mmHg, pulse rate was 140 beats per minute, respiratory rate 24 breaths per minute and pulse oximetry was 100070 while on oxygen at 15 litres per minute via Hudson mask. The remainder of the examination was unremarkable. Twelve-lead electrocardiogram showed a bidirectional tachycardia with sinus node arrest ( Figure 1 ). Portable supine AP chest X-ray was normal, as was full blood count. Potassium, glucose, creatinine and urea were all mildly elevated. Urinary drug screen was negative for tricydics, barbiturates and benzodiazapines. Serum theophylline was zero and serum digoxin was less than 0.3 nmoIlI.
Soon after admission he developed non-sustained ventricular tachycardia (VT). He remained conscious. An amiodarone infusion of 300 mg was commenced. He subsequently developed longer periods of VT, progressing to Torsade de Pointes and ventricular fibrillation. Cardiopulmonary resuscitation (CPR) was commenced, he was intubated and over the ensuing three hours he was treated with multiple cardioversions (30) and anti-arrhythmics including amiodarone 300 mg (total), sotalol 220 mg, magnesium 30 mmol and bretylium 1175 mg. He was given adrenaline 15.5 mg and NaHC0 3 100 mmol. Initially, short periods of spontaneous output lasting less than one minute were obtained immediately after cardioversion. However, tachyarrhythmias were increasingly refractory to treatment and the pupils became dilated and unresponsive to light. A decision to proceeed to cardiopulmonary bypass was made. He developed profound bradycardia while being transported to the operating room while still receiving CPR. Following emergency median sternotomy, full cardiopulmonary bypass was instituted using a single aortic and a single right atrial cannula. The ventricles on tactile stimulation were noted to be contractile, although still profoundly bradycardic. lWo right ventricular (RV) pacing wires were inserted and a pacing rate of 90/min was commenced. With pacing and inotropic support with adrenaline, RV output appeared to be functionally adequate; however, the left ventricle (LV) was severely dysfunctional. Left ventricular support via a left ventricular assist device (LVAD) (Bio-Medicus centrifugal pump), using a left atrial cannula to an ascending aortic cannula, was commenced. LVAD output was set at 3.5 lImin and a good urine output was achieved. Sedation and muscle relaxation was required when the patient began to breathe spontaneously and sweat. The chest remained open, was packed and dressed, and he was transferred to the Intensive Care Vnit (ICV). The LVAD flow remained at 3.5 lImin. Inotropic support, RV pacing, mechanical ventilation and sedation continued. A pulmonary artery oximetric catheter was inserted and mixed venous oxygen saturation (SV02) and cardiac outputs were serially monitored.
The postoperative period was complicated by coagulopathy and extensive blood loss from mediastinal drains, requiring transfusion with 17 units of packed Multiple VEBs and short periods of VT occurred initially, but sinus rhythm was restored 12 hours after arrival in the ICU. Pacing was ceased soon after. nans-oesophageal echocardiography showed normal LV and RV size and function. The LVAD was ceased and SV02 and serial cardiac output monitoring confirmed adequate LV function. After 24 hours on LVAD, the patient was returned to the operating room for decannulation and closure of the sternotomy wound. Inotropic support and sedation were rapidly weaned and he was extubated the following day. The patient showed no obvious neurological deficit, having complete recall of events leading to admission to hospital. He had limited awareness of his resuscitation, but no recall of operative procedures. Recovery was rapid and he was discharged six days following admission.
Herb samples were sent to the Therapeutic Goods Administration (TGA) for analysis. Chromatographic profiles using high performance liquid chromatography (HPLC) and thin layer chromatography (TLC) closely matched verified samples of A. carmichaeli and A. kuznezoffii obtained by the TGA. Aconite alkaloids were also detected using a wet chemical procedure as detailed in the British Pharmacopoeia.
DISCUSSION
The genus Aconitum belongs to the Ranunculaceae family and is widely distributed throughout the Northern Hemisphere. There are over 350 species world-wide and approximately 170 in China alone. Aconite tubers are among the most toxic plants known but have been used in Eastern and Western therapeutics for centuries. The raw tuber is usually processed by drying, soaking or boiling, which significantly reduces its toxicity.
In Europe, aconite is derived from the species Aconitum Napellus, also known as Monkshood or Wolfsbane. It achieved some notoriety in the 19th century as an agent for homicides and suicides, when it was readily available as both a liniment for the treatment of neuralgias, lumbago and bruising, or as a tincture to be taken internally for the treatment of fevers and inflammations 2 . Aconite last appeared in the British Pharmacopoeia in 1953 3 and is now only used in Western countries as a proarrhythmic agent in animal studies to test the efficacy of antiarrhythmic agents'.
In China, aconite is usually derived from A. carmichaeli (chuanwu) or A. kuznezoffii (caowu)5. It was well known as an arrow poison, but has also been used medicinally for its analgesic, antirheumatic and cardiotonic properties, appearing in the Ben Cao Materia Medica from the second century6. There have been controls over the prescription of aconites in China and Taiwan since 1984 7 • In Hong Kong at present there are no regulatory controls and it is estimated that 751110 of Chinese herbal medicine related admissions to hospital are due to aconite toxicity8.
Toxicity is due to aconite alkaloids (C19 diterpinoid esters), which vary quantitatively and qualitatively, depending on the species type, place of origin, time of harvest, method of preparation of the plant, and duration of decoction, recommended to be 30 to 60 minutes 5 . The alkaloids are sodium channel activators which affect all excitable tissues. Clinically, this results in oral anaesthesia if ingested, widespread sensory and motor symptoms and signs, nausea, vomiting and diarrhoea, and cardiotoxicity. Cardiotoxicity is due to an indirect effect (via stimulation of the vagal medullary centre) resulting in bradycardia, sinus node arrest and hypotension, and a direct effect on the myocardium, in which prolonged repolarisation results in triggered automaticity and a variety of tachyarrhythmias. Symptoms of poisoning usually occur within an hour of ingestion. The time course and history described by our patient were highly suggestive of aconite poisoning. Furthermore, our patient's presenting ECG showed bidirectional tachycardia, a rare arrhythmia which has previously been reported in aconite toxicity9. Aconite cardiotoxicity typically resolves within 24 hours, as was the case with our patient, who was de-cannulated within 24 hours of insertion of the LVAD.
Management of cardiotoxicity has remained a therapeutic challenge, as the ideal drug therapy for aconite-induced tachyarrhythmias is not known"iO. In the Chinese and herbal literature atropine and lignocaine have long been suggested as treatments for toxicity5,1I. In cat studies, atropine has been shown to be effective in antagonising aconitine-induced cardiodepression and in preventing atrial fibrillation, suggesting a cholinergic action of aconitine'. However, reports of atropine in the clinical treatment of aconiteinduced tachyarrhythmias are uncommon and inconclusive. In more recent literature lignocaine in standard doses has been reported as being unsuccessful', 9, 12, 13 . Anecdotal reports of resolution of arrhythmias with flecainide " \ mexiletine 14 , procainamide ' 2 ,13, amiodarone ' and phenytoin '2 have appeared in the literature. Tai et all, in a series of 17 severe intoxications, found no single anti-arrhythmic agent to be uniformly effective. However, suppression of VT was eventually achieved in nine patients with amiodarone (5), flecainide (2), procainamide (1) and mexiletine (1). All patients received lignocaine.
Aconite cardiotoxicity is also characterised by the failure of DC cardioversion to correct tachyarrhythmias ' · 9 ,'2,'5. Transvenous pacing has also been shown to be ineffective 15 . Mechanical circulatory support has been attempted unsuccessfully '6. Our patient was refractory to multiple DC cardioversions and anti-arrhythmics (amiodarone, sotalol, magnesium and bretylium) and as a last resort mechanical circulatory support was instituted using full CPB and, subsequently, an LVAD. The advantages of an LVAD over full CPB include a lower requirement for anticoagulation, the possibility of less secondary lung injury and a lesser need for specifically trained personnel.
Aconites have been an S4 listing in Australia since January 1992. Prior to March 1994 toxic herbs or plants, including aconite species, could be imported or sold as or in food products, and were exempt from State and Territory Scheduled Poisons listings. An amendment to the Australian Food Standards now closes this loophole; however, despite the legislatory regulations on the importation and prescription of herbal medicines, the policing of these may be difficult. In Australia there is no regulatory authority of Chinese herbalists although efforts at self-regulation have occurred. The increasing use and reported adverse effects of herbal remedies have prompted the TGA to recently form the Traditional Medicines Evaluation Anaesthesia and Intensive Care, Vol. 22, No. 6, December, 1994 Committee to monitor the use of alternative medicines in Australia.
In conclusion, we report a case that, to our knowledge, is the first where aconite cardiac toxicity has been successfully managed with CPB and the utilisation of an LVAD. Early institution of CPB may be beneficial in this clinical setting. Clinicians and the general public should be aware of the potential adverse effects of herbal remedies. With increasing use of herbal remedies an assessment of the regulations and controls on the importation and prescription of herbal therapies is urgently required.
